Your browser doesn't support javascript.
loading
Global Divergence From World Health Organization Treatment Guidelines for Neonatal and Pediatric Sepsis.
Jackson, Charlotte; Hsia, Yingfen; Basmaci, Romain; Bielicki, Julia; Heath, Paul T; Versporten, Ann; Goossens, Herman; Sharland, Mike.
Afiliación
  • Jackson C; From the Paediatric Infectious Diseases Research Group, Institute of Infection and Immunity, St George's, University of London, London, United Kingdom.
  • Hsia Y; From the Paediatric Infectious Diseases Research Group, Institute of Infection and Immunity, St George's, University of London, London, United Kingdom.
  • Basmaci R; Service de Pédiatrie-Urgences, Hôpital Louis-Mourier, APHP, Colombes, France.
  • Bielicki J; INSERM, Infection, Antimicrobiens, Modélisation, Evolution (IAME), UMR1137, Université Paris Diderot - Sorbonne Paris Cité, Paris, France.
  • Heath PT; From the Paediatric Infectious Diseases Research Group, Institute of Infection and Immunity, St George's, University of London, London, United Kingdom.
  • Versporten A; Paediatric Pharmacology and Paediatric Infectious Diseases, University Children's Hospital Basel, Basel, Switzerland.
  • Goossens H; From the Paediatric Infectious Diseases Research Group, Institute of Infection and Immunity, St George's, University of London, London, United Kingdom.
  • Sharland M; Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), Faculty of Medicine and Health Science, University of Antwerp, Antwerp, Belgium.
Pediatr Infect Dis J ; 38(11): 1104-1106, 2019 11.
Article en En | MEDLINE | ID: mdl-31425329
ABSTRACT
We used data from 2 global point prevalence surveys of antibiotic prescribing to describe the treatment of sepsis in hospitalized neonates and children. One hundred eighty-five of 824 neonates (22.5%) and 9/786 children (1.1%) received a World Health Organization-recommended first-line treatment; of the remainder, 9/639 neonates (1.4%) and 102/777 children (13.1%) received a World Health Organization-recommended second-line treatment. Reasons for this low adherence to guidance should be explored.
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 2_ODS3 Problema de salud: 2_cobertura_universal Asunto principal: Organización Mundial de la Salud / Sepsis / Adhesión a Directriz / Antibacterianos Tipo de estudio: Guideline / Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Adolescent / Child / Child, preschool / Humans / Infant / Newborn Idioma: En Revista: Pediatr Infect Dis J Asunto de la revista: DOENCAS TRANSMISSIVEIS / PEDIATRIA Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 2_ODS3 Problema de salud: 2_cobertura_universal Asunto principal: Organización Mundial de la Salud / Sepsis / Adhesión a Directriz / Antibacterianos Tipo de estudio: Guideline / Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Adolescent / Child / Child, preschool / Humans / Infant / Newborn Idioma: En Revista: Pediatr Infect Dis J Asunto de la revista: DOENCAS TRANSMISSIVEIS / PEDIATRIA Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido